321 related articles for article (PubMed ID: 35501821)
1. Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target.
Qie S; Sang N
J Exp Clin Cancer Res; 2022 May; 41(1):161. PubMed ID: 35501821
[TBL] [Abstract][Full Text] [Related]
2. Stanniocalcin-2 (STC2): A potential lung cancer biomarker promotes lung cancer metastasis and progression.
Na SS; Aldonza MB; Sung HJ; Kim YI; Son YS; Cho S; Cho JY
Biochim Biophys Acta; 2015 Jun; 1854(6):668-76. PubMed ID: 25463045
[TBL] [Abstract][Full Text] [Related]
3. Expression of Stanniocalcin 2 in Breast Cancer and Its Clinical Significance.
Jiang ST; Wang HQ; Yang TC; Wang DW; Yang LJ; Xi YQ; Kong FZ; Pan XK; Xu LH; Feng MH; Xie W; Su F
Curr Med Sci; 2019 Dec; 39(6):978-983. PubMed ID: 31845230
[TBL] [Abstract][Full Text] [Related]
4. STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial-Mesenchymal Transition.
Lin C; Sun L; Huang S; Weng X; Wu Z
Biomed Res Int; 2019; 2019():8042489. PubMed ID: 32258098
[TBL] [Abstract][Full Text] [Related]
5. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia.
Law AY; Wong CK
Exp Cell Res; 2010 Feb; 316(3):466-76. PubMed ID: 19786016
[TBL] [Abstract][Full Text] [Related]
6. Identification of a stanniocalcin paralog, stanniocalcin-2, in fish and the paracrine actions of stanniocalcin-2 in the mammalian ovary.
Luo CW; Pisarska MD; Hsueh AJ
Endocrinology; 2005 Jan; 146(1):469-76. PubMed ID: 15486227
[TBL] [Abstract][Full Text] [Related]
7. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells.
Law AY; Wong CK
Exp Cell Res; 2010 Dec; 316(20):3425-34. PubMed ID: 20619259
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma.
Wang Y; Wu J; Xu J; Lin S
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30962272
[TBL] [Abstract][Full Text] [Related]
9. Stanniocalcin 2 contributes to aggressiveness and is a prognostic marker for oral squamous cell carcinoma.
Ferreira do Carmo A; Dourado MR; Ervolino de Oliveira C; Bastos DC; Domingueti CB; Ribeiro Paranaíba LM; Sawazaki-Calone Í; Borges GÁ; Silva Guerra EN; Casarin RC; Graner E; Salo TA; de Almeida Freitas R; Galvão HC; Coletta RD
Exp Cell Res; 2020 Aug; 393(2):112092. PubMed ID: 32445747
[TBL] [Abstract][Full Text] [Related]
10. Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer.
Coulson-Gilmer C; Humphries MP; Sundara Rajan S; Droop A; Jackson S; Condon A; Cserni G; Jordan LB; Jones LJ; Kanthan R; Di Benedetto A; Mottolese M; Provenzano E; Kulka J; Shaaban AM; Hanby AM; Speirs V
J Pathol Clin Res; 2018 Oct; 4(4):241-249. PubMed ID: 29956502
[TBL] [Abstract][Full Text] [Related]
11. Stanniocalicin 2 suppresses breast cancer cell migration and invasion via the PKC/claudin-1-mediated signaling.
Hou J; Wang Z; Xu H; Yang L; Yu X; Yang Z; Deng Y; Meng J; Feng Y; Guo X; Yang G
PLoS One; 2015; 10(4):e0122179. PubMed ID: 25830567
[TBL] [Abstract][Full Text] [Related]
12. Expression of stanniocalcin-1 and stanniocalcin-2 in laryngeal squamous cell carcinoma and correlations with clinical and pathological parameters.
Zhou H; Li YY; Zhang WQ; Lin D; Zhang WM; Dong WD
PLoS One; 2014; 9(4):e95466. PubMed ID: 24743310
[TBL] [Abstract][Full Text] [Related]
13. Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas.
Lin S; Guo Q; Wen J; Li C; Lin J; Cui X; Sang N; Pan J
J Exp Clin Cancer Res; 2014 Mar; 33(1):26. PubMed ID: 24606961
[TBL] [Abstract][Full Text] [Related]
14. Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma.
Li JB; Liu ZX; Zhang R; Ma SP; Lin T; Li YX; Yang SH; Zhang WC; Wang YP
World J Gastroenterol; 2019 Jun; 25(22):2776-2787. PubMed ID: 31236000
[TBL] [Abstract][Full Text] [Related]
15. STC2 overexpression mediated by HMGA2 is a biomarker for aggressiveness of high-grade serous ovarian cancer.
Wu J; Lai M; Shao C; Wang J; Wei JJ
Oncol Rep; 2015 Sep; 34(3):1494-502. PubMed ID: 26165228
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA HOTAIR/microRNA-206 sponge regulates STC2 and further influences cell biological functions in head and neck squamous cell carcinoma.
Li T; Qin Y; Zhen Z; Shen H; Cong T; Schiferle E; Xiao S
Cell Prolif; 2019 Sep; 52(5):e12651. PubMed ID: 31297902
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Yanagita S; Hagihara T; Haraguchi N; Matsushita D; Hirahara T; Okumura H; Uchikado Y; Nakajo A; Hokita S; Natsugoe S
Oncol Rep; 2013 Dec; 30(6):2838-44. PubMed ID: 24100594
[TBL] [Abstract][Full Text] [Related]
18. Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells.
He H; Qie S; Guo Q; Chen S; Zou C; Lu T; Su Y; Zong J; Xu H; He D; Xu Y; Chen B; Pan J; Sang N; Lin S
Cancer Manag Res; 2019; 11():6411-6424. PubMed ID: 31372045
[No Abstract] [Full Text] [Related]
19. Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro.
Raulic S; Ramos-Valdes Y; DiMattia GE
J Endocrinol; 2008 Jun; 197(3):517-29. PubMed ID: 18492817
[TBL] [Abstract][Full Text] [Related]
20. STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro.
Wang H; Wu K; Sun Y; Li Y; Wu M; Qiao Q; Wei Y; Han ZG; Cai B
BMB Rep; 2012 Nov; 45(11):629-34. PubMed ID: 23187001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
